US2017136069A1PendingUtilityA1
Cell carrier and cell carrier containment devices containing regenerative cells
Est. expiryDec 7, 2021(expired)· nominal 20-yr term from priority
A61F 2002/30593A61F 2002/30075C12N 5/0667A61F 2002/30879A61F 2002/30841A61F 2/4465A61K 9/0019A61K 35/28A61K 35/32A61F 2/447A61F 2220/005A61F 2002/30448A61F 2002/4445A61F 2230/0015C12N 2506/1384A61F 2002/30133A61F 2002/445A61F 2210/0061A61F 2002/30062A61F 2210/0004A61F 2/442B33Y 80/00A61F 2/4455C12N 5/069A61F 2002/30604
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a device comprising a cell carrier portion containing regenerative cells, e.g., stem and progenitor cells, and a cell carrier containment portion. The device is useful for the treatment of bone related disorders, including spinal fusion related disorders and long bone or flat bone related defects. The device may be used in conjunction with disclosed automated systems and methods for separating and concentrating regenerative cells.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a patient, comprising:
(a) providing a tissue removal system; (b) removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; (c) processing at least a part of the adipose tissue to obtain a concentration of stem cells other than the concentration of stem cells of the adipose tissue before processing; and (d) administering the stem cells to a patient without removing the stem cells from the tissue removal system before being administered to the patient.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.